Abstract
The aim of this study was to evaluate the frequency of surgical approach in a population of patients affected by definite Menière’s disease (MD). In the majority of patients, relief from vertigo attacks can be achieved by means of medical therapy (MT). In cases in which MT fails surgery may offer relief to vertigo. The most applied surgical procedures are intratympanic gentamicin (ITG) and vestibular neurectomy (VN), based on vestibular deafferentation. Until now, the real incidence of the different therapeutic approaches for MD has not been evaluated. The study design was a retrospective study. The study was performed in 177 patients affected by definite MD. Subjects referred directly for surgery by other centers were excluded from the study. All the patients were medically treated with salt restriction and diuretics. In case of MT failure, surgical therapy, ITG or retrosigmoid VN were proposed. In the 75% of cases, the only therapeutic approach was MT, while in 20% of cases we carried out ITG and in 5% VN. In 33% of VN group, this operation was carried out after ITG failure and in 67% as the first surgical approach. The VN group was characterized by younger age and higher disability degree. The primary therapy in definite MD seems to be MT. Ablative therapy represents the second choice: ITG was carried out in 80% of cases, while VN was performed in 20%.
Similar content being viewed by others
References
Menière P (1861) Sur une forme de sourdité grave dependant d’une lesion de l’oreille interne. Gaz Med Paris 16:29
Baloh RW (2001) Prosper Menière and his disease. Arch Neurol 58:1151–1156
Sajjadi H, Paparella MM (2008) Menière’s disease. Lancet 372:406–414
Committee on hearing, equilibrium AAO-HNS (1995) Guidelines for the diagnosis and evaluation of therapy in Menière disease. Otolaryngol Head Neck Surg 113:181–185
Stahle J, Stahle C, Arenberg IK (1978) Incidence of Menière’s disease. Arch Otolaryngol 104:99–102
Minor LB, Schessel DA, Carey JP (2004) Menière’s disease. Curr Opin Neurol 17:9–16
Schuknecht HF (1956) Ablation therapy for the relief of Menière’s disease. Laryngoscope 66:859–870
Stokroos R, Kingma H (2004) Selective vestibular ablation by intratympanic gentamicin in patients with unilateral active Menière’s disease: a prospective, double blind, placebo controlled, randomized clinical trial. Acta Otolaryngol 124:172–175
Nakai Y, Hilding D (1968) Vestibular endolymph-producing epithelium. Electron microscopic study of the development and histochemistry of the dark cells of the crista ampullaris. Acta Otolaryngol 66:120–128
Tucci DL, Rubel EW (1990) Physiologic status of regenerated hair cells in the avian inner ear following aminoglycoside ototoxicity. Otolaryngol Head Neck Surg 103:443–450
Silverstein H, Norrell H, Wanamaker H, Flanzer J (1991) Microsurgical posterior fossa vestibular neurectomy: an evolution in technique. Skull Base Surg 1:16–24
Dandy WE (1928) Menière’s disease: its diagnosis and a method of treatment. Arch Surg 16:1127–1152
McKenzie KG (1936) Intracranial division of the vestibular portion of the auditory nerve for Menière’s disease. CMAJ 34:369–381
Jackler RK, Whinney D (2001) A century of eighth nerve surgery. Otol Neurotol 22:401–416
Perez R, Ducati A, Garbossa D, Benech F, Fontanella MM, Canale A, Albera R (2005) Retrosigmoid approach for vestibular neurectomy in Menière’s disease. Acta Neurochir (Wien) 147:401–404
Silverstein H, Norrell H, Smouha EE (1987) Retrosigmoid-internal auditory canal approach vs. retrolabyrinthine approach for vestibular neurectomy. Otolaryngol Head Neck Surg 97:300–307
McKenna MJ, Nadol JB Jr, Ojemann RG, Halpin C (1996) Vestibular neurectomy: retrosigmoid-intracanalicular versus retrolabyrinthine approach. Am J Otol 17:253–258
Chia SH, Gamst AC, Anderson JP, Harris JP (2004) Intratympanic gentamicin therapy for Menière’s disease: a meta-analysis. Otol Neurotol 25:544–552
Van de Heyning PH, Wuyts F, Boudewyns A (2005) Surgical treatment of Menière’s disease. Curr Opin Neurol 18:23–28
Hillman TA, Chen DA, Arriaga MA (2004) Vestibular nerve section versus intratympanic gentamicin for Menière’s disease. Laryngoscope 114:216–222
Colletti V, Carner M, Colletti L (2007) Auditory results after vestibular nerve section and intratympanic gentamicin for Menière disease. Otol Neurotol 28:145–151
Filipo R, Barbara M (1997) Natural history of Menière’s disease: staging the patients or their symptoms. Acta Otolaryngol Suppl 526:10–13
Kerr AG, Toner LG (1988) A new approach to surgery for Menière’s disease: talking about surgery. Clin Otalaryngol 23:263–264
Nguyen KH, Minor LB, Della santina CC, Carey JP (2009) Time course of intratympanic gentamicin for Menière’s disease. Laryngoscope 119:792–798
Odkvist LM, Bergenius J, Moller C (1997) When and how to use gentamicin in the treatment of Menière’s disease. Acta Otolaryngol 526 Suppl:54–57
Kamei T (2004) Delayed endolymphatic hydrops as a clinical entity. Int Tinnitus J 10:137–143
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Albera, R., Canale, A., Parandero, F. et al. Surgical indication in Menière’s disease therapy: clinical and epidemiological aspects. Eur Arch Otorhinolaryngol 268, 967–972 (2011). https://doi.org/10.1007/s00405-011-1490-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-011-1490-5